Cargando…
Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study
PURPOSE: The FIGARO study aims to provide insights on real-world utilization and tolerability of facilitated subcutaneous immunoglobulin (fSCIG) for primary immunodeficiency disease (PID) or secondary immunodeficiency disease (SID). METHODS: This prospective, multicenter, observational study, evalua...
Autores principales: | Borte, Michael, Hanitsch, Leif G., Mahlaoui, Nizar, Fasshauer, Maria, Huscher, Dörte, Speletas, Matthaios, Dimou, Maria, Kamieniak, Marta, Hermann, Corinna, Pittrow, David, Milito, Cinzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088636/ https://www.ncbi.nlm.nih.gov/pubmed/37036560 http://dx.doi.org/10.1007/s10875-023-01470-2 |
Ejemplares similares
-
Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis
por: Dimou, Maria, et al.
Publicado: (2023) -
P1611: INSIGHTS INTO FACILITATED IMMUNOGLOBULIN (FSCIG) USE IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DISEASES: FINAL RESULTS FROM THE FIGARO STUDY
por: Dimou, M., et al.
Publicado: (2022) -
Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases
por: Fasshauer, Maria, et al.
Publicado: (2023) -
Figaro illustré.
Publicado: (1908) -
El Fígaro : revista universal ilustrada.
Publicado: (1885)